62820-50-2

4(3H)-Quinazolinone, 2-(2-furanyl)-3-(4-methylphenyl)-

1,5-Naphthyridine-3-carboxamide, 4-chloro-6-methoxy-

1,5-Octadiene, (5E)-

1,3-Cyclopentadiene, 5-cyclobutylidene-2-methyl-

1,5-Nonadien-4-ol,3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9-[(4-methoxyphenyl)methoxy]-2-methyl-, (3R,4R,5E)-

1,5-Naphthyridine,8-[[1-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-4-piperidinyl]methoxy]-2-methoxy-, hydrochloride

1,5-Naphthyridine-3-carboxamide,N-[(4-chlorophenyl)methyl]-4-hydroxy-6-(4-morpholinylmethyl)-

1,3-Cyclopentadiene, trichlorotriethyl-

Piperidine,1-[[6-(7-chloro-1,8-naphthyridin-2-yl)-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-7-yl]acetyl]-

2,4-Dimethylpyrimidine-5-carbaldehyde

2-Pyrrolidinecarboxamide,N-[(1S)-7-oxo-1-[[[2-(2-phenyl-1H-indol-3-yl)ethyl]amino]carbonyl]octyl]-,(2S)-

Benzeneacetamide, N-(3,5-diaminophenyl)-

Piperazine,1-[(methylamino)acetyl]-4-[3-[4-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]phenoxy]propyl]-, rel-, bis(trifluoroacetate)

1,5-Naphthyridin-2(1H)-one,1-butyl-3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-

1H-Indole-2-carboxamide, 2,3-dihydro-N-propyl-, (2S)-

1,4-Dioxaspiro[4.11]hexadecane, 2,3-bis(2-nitrophenyl)-, (2R,3R)-rel-

1,4-Dioxaspiro[4.11]hexadecane-7-carbonitrile, 8-ethyl-

3-Pyridinesulfonamide,N-(2-benzoyl-5-chloro-3-pyridinyl)-6-(1-methylethoxy)-

Benzenesulfonamide,N-(5-chloro-2-phenoxy-3-pyridinyl)-4-(1-methylethoxy)-

1,5-Pentalenedione, 2,3,6,6a-tetrahydro-6a-methyl-

1,3-Cyclopentanedicarboxylic acid, 1,2,2-trimethyl-

Benzenesulfonamide,N-[5-chloro-2-(2-methylbenzoyl)-3-pyridinyl]-4-(1,1-dimethylethyl)-

1,4-Dioxaspiro[4.5]dec-7-ene-8-carboxamide, N-(2-hydroxyphenyl)-

1,5-Naphthyridine, decahydro-1,5-dimethyl-

1,3-Cyclopentadiene, 5-(3-chloro-2-propenylidene)-

1H-Indole-3-acetamide,N-[(1S)-1-[[[(2,3-dihydro-1H-inden-2-yl)methyl]amino]carbonyl]-7-oxooctyl]-5-methoxy-2-methyl-

1,5-Octadiene, 1,8-diiodo-2,6-dimethyl-, (1E,5E)-

1,3-Cyclopentanedicarboxylic acid, 4,5-bis[[(methylsulfonyl)oxy]methyl]-,dimethyl ester, (1R,3S,4S,5R)-rel-

Piperazine,1-[[(1S,3R)-3-[(3-ethyltetrahydro-2H-pyran-4-yl)amino]-1-(1-methylethyl)cyclopentyl]carbonyl]-4-[3-(trifluoromethyl)phenyl]-

1,5-Naphthyridin-2(1H)-one, 3-(3-methyl-5-isoxazolyl)-4-phenyl-

Benzenesulfonamide,4-chloro-N-[5-chloro-2-[2-methyl-6-(methylsulfonyl)benzoyl]-3-pyridinyl]-3-(trifluoromethyl)-

4,6-dichloro-1,3-benzothiazole-2(3H)-thione

1,4-Dioxane-2-carboxaldehyde, 3-[(phenylmethoxy)methyl]-, (2R,3S)-

(1-biphenyl-3-yl-1H-imidazol-4-yl)-(4-methoxy-phenyl)-methanone

1,3-Cyclopentanedicarboxylic acid, 1,2-dimethyl-2-(phenylmethyl)-,1-methyl ester, (1R,2S,3S)-

Benzenesulfonamide,N-[5-chloro-2-[3-(methylthio)benzoyl]-3-pyridinyl]-4-(1,1-dimethylethyl)-

1,5-Naphthyridinium, 1-methyl-, iodide

62820-50-2 msds

CAS No 62820-50-2 supplier

CASNo 62820-50-2 distributor

CAS # 62820-50-2 manufacturer

CAS Number 62820-50-2 safety

CAS RN 62820-50-2 wholesale

2026-10-15 Find 4(3H)-Quinazolinone, 2-(2-furanyl)-3-(4-methylphenyl)-,CAS No.62820-50-2,Formula:C19H14N2O2 in ChemToTech